BTK
Les inhibiteurs de la tyrosine kinase de Bruton (BTK) sont des composés qui ciblent spécifiquement et inhibent la BTK, une enzyme cruciale impliquée dans la signalisation du récepteur des cellules B et la régulation de l'angiogenèse. La BTK joue un rôle significatif dans la prolifération et la survie des cellules cancéreuses, en particulier dans les malignités hématologiques. En inhibant la BTK, ces composés peuvent perturber l'angiogenèse et la croissance tumorale, ce qui les rend précieux en thérapie anticancéreuse. Chez CymitQuimica, nous offrons une gamme d'inhibiteurs de la BTK de haute qualité pour soutenir vos recherches en oncologie, immunologie et angiogenèse.
168 produits trouvés pour "BTK".
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
FDU73
FDU73 is a potent and selective BTK PROTAC degrader with a DC50 of 2.9 nM in JeKo-1 cells. It inhibits tumor cell proliferation and exhibits antitumor activity.Couleur et forme :Odour SolidBRK inhibitor P21d hydrochloride
CAS :BRK inhibitor P21d HCl targets breast tumor kinase with 30 nM IC50, suppresses p-SAM68 at 52 nM, useful for in vivo breast cancer research.Formule :C23H23ClFN7O2Couleur et forme :SolidMasse moléculaire :483.93LFM-A13
CAS :LFM-A13 is a highly selective BTK inhibitor; IC50 2.5 uM; targets catalytic domain; severs BCR signaling; anti-leukemic; autoimmune disease and lymphocytic leukemia research.Formule :C11H8Br2N2O2Degré de pureté :99.50%Masse moléculaire :360L18I
L18I is a PROTAC (Proteolysis Targeting Chimera) that targets Btk to mitigate inflammation in autoimmune diseases. The components of L18I include the PROTAC target protein ligand IBT6A, the PROTAC linker Propargyl-PEG3-alcohol, and the E3 ubiquitin ligase ligand Lenalidomide-Br. Notably, the active control for the target protein ligand is IBT6A-CO-ethyne, while the conjugate of the E3 ubiquitin ligase ligand with the linker is Lenalidomide-C3-PEG3-N3.Formule :C47H51N11O8Couleur et forme :SolidMasse moléculaire :897.98PROTAC BTK Degrader-10
CAS :PROTAC BTK Degrader-10 (Example 1P) is a PROTAC compound that targets BTK for degradation. It is applicable in the research of chronic lymphocytic leukemia (CLL). [Pink: ligand for target protein; Black: linker; Blue: ligand for E3 ligase Cereblon].Formule :C42H49N11O4Couleur et forme :SolidMasse moléculaire :771.91BTK-IN-40
CAS :BTK-IN-40 (compound 375) is an inhibitor of BTK.Formule :C20H25N7O2Couleur et forme :SolidMasse moléculaire :395.46BTK ligand-14
BTKligand-14 is a PROTAC-targeting ligand for BTK, suitable for the synthesis of FDU73.Couleur et forme :Odour SolidIBT6A hydrochloride
CAS :IBT6A hydrochloride: Ibrutinib impurity, Btk inhibitor IC50: 0.5 nM, used in dimer/adduct synthesis.Formule :C22H23ClN6OCouleur et forme :SolidMasse moléculaire :422.91Elsubrutinib
CAS :Elsubrutinib (ABBV-105) is an orally active, selective, and irreversible BTK inhibitor with an IC50 of 0.18 μM for the catalytic domain of BTK.Formule :C17H19N3O2Degré de pureté :99.77%Couleur et forme :White SolidMasse moléculaire :297.36Ref: TM-T39130
1mg145,00€5mg250,00€10mg340,00€1mL*10mM (DMSO)356,00€25mg573,00€50mg879,00€100mg1.314,00€Zanubrutinib-D5
Zanubrutinib-d5 (BGB-3111-d5) is a deuterium-labeled Zanubrutinib, an orally available Bruton's tyrosine kinase inhibitor for the study of B-cell malignancies.Formule :C27H29N5O3Degré de pureté :>99.99%Couleur et forme :White SolidMasse moléculaire :476.58GDC-0834
CAS :GDC-0834 inhibits BTK with an in vitro IC50 of 5.9 and 6.4 nM in biochemical and cellular assays, respectively, and in vivo IC50 of 1.1 and 5.6 μM in mouse andFormule :C33H36N6O3SCouleur et forme :SolidMasse moléculaire :596.74NX-5948
CAS :NX-5948 (BTK-IN-24) is a PROTAC-type BTK degrader with anti-inflammatory and anticancer activities, inhibiting B cell activation.Formule :C42H54N12O5Degré de pureté :98.29%Couleur et forme :SolidMasse moléculaire :806.96Ref: TM-T75124
1mg80,00€5mg145,00€1mL*10mM (DMSO)178,00€10mg212,00€25mg339,00€50mg510,00€100mg708,00€N-piperidine Ibrutinib hydrochloride
CAS :N-piperidine Ibrutinib hydrochloride is a BTK inhibitor that inhibits WT BTK and C481S BTK , which inhibits the growth and proliferation of cancer cells.Formule :C22H23ClN6ODegré de pureté :98.83%Couleur et forme :SolidMasse moléculaire :422.91Poseltinib
CAS :Poseltinib is an oral, irreversible BTK inhibitor (IC50 1.95 nM) with higher selectivity over BMX, TEC, and TXK, blocking BCR, FcR, and TLR signaling.Formule :C26H26N6O3Degré de pureté :99.98%Couleur et forme :Yellow SolidMasse moléculaire :470.52Ref: TM-T4413
2mg34,00€5mg49,00€1mL*10mM (DMSO)50,00€10mg75,00€25mg146,00€50mg260,00€100mg409,00€200mg590,00€Anti-BTK Antibody (3G585)
Anti-BTK Antibody (3G585) is an antibody targeting BTK. Anti-BTK Antibody (3G585) can be used in ELISA, IHC.Couleur et forme :Odour LiquidOlmutinib
CAS :Olmutinib is an oral mutant-specific EGFR inhibitor for cancer treatment with potential lower toxicity.Formule :C26H26N6O2SDegré de pureté :99.14% - 99.63%Couleur et forme :SolidMasse moléculaire :486.59Ref: TM-T6918
2mg37,00€5mg54,00€1mL*10mM (DMSO)56,00€10mg84,00€25mg130,00€50mg170,00€100mg268,00€200mg437,00€Tuxobertinib
CAS :Tuxobertinib (BDTX-189) is a potent and selective inhibitor of allosteric EGFR and HER2 oncogenic mutations. BDTX-189 exhibits anticancer activity.Formule :C29H29ClN6O4Degré de pureté :99.22%Couleur et forme :SolidMasse moléculaire :561.03Ref: TM-T9072
2mg38,00€5mg57,00€1mL*10mM (DMSO)71,00€10mg90,00€25mg178,00€50mg334,00€100mg497,00€200mg712,00€BMS-986142
CAS :BMS-986142 is a potent and highly selective reversible BTK inhibitor (IC50: 0.5 nM).Formule :C32H30F2N4O4Degré de pureté :99.44% - 99.76%Couleur et forme :SolidMasse moléculaire :572.6Ref: TM-T5138
1mg105,00€2mg165,00€5mg289,00€1mL*10mM (DMSO)358,00€10mg447,00€25mg715,00€50mg964,00€100mg1.243,00€200mg1.693,00€CGI-1746
CAS :CGI1746 is a potent and highly selective small-molecule Btk inhibitor with IC50 of 1.9 nM.Formule :C34H37N5O4Degré de pureté :97.69% - 97.88%Couleur et forme :White SolidMasse moléculaire :579.69(Z)-LFM-A13
CAS :(Z)-LFM-A13(IC50=2.5 μM), a specific Bruton's tyrosine kinase (BTK), is more than 100-fold specificity than other protein kinases, such as JAK1, JAK2, HCK, EGFR, and IRK.Formule :C11H8Br2N2O2Degré de pureté :99.88%Couleur et forme :SolidMasse moléculaire :360
